GM 2025 News

Open letter to the OSE Immunotherapeutics Shareholders

Dear OSE Immunotherapeutics Shareholders, As co-founders and former directors of OSE Immunotherapeutics, we intimately understand the company’s innovations, their commercial potential, and the paths to success. We remain major shareholders because we believe in the…

Read all

GM 2025 News

https://ose-ag2025.com/wp-content/uploads/2025/06/biotech.webp 600 400 OSE-AG25 OSE-AG25 https://ose-ag2025.com/wp-content/uploads/2025/06/biotech.webp 18 June 2025 18 June 2025

Letter to the shareholders in connection with the Combined General Meeting of OSE Immunotherapeutics SA to be held on June 25, 2025

In order to explain the reasons for the 10 draft resolutions which we have requested to be included on the agenda Dear Shareholders, As co-founders and former directors of OSE Immunotherapeutics, we are concerned about…

Read all

GM 2025 News

https://ose-ag2025.com/wp-content/uploads/2025/06/OSE-Pharma-Loria-Costantini-Peyroles-e1445893203257-1.jpg 1536 1024 OSE-AG25 OSE-AG25 https://ose-ag2025.com/wp-content/uploads/2025/06/OSE-Pharma-Loria-Costantini-Peyroles-e1445893203257-1.jpg 18 June 2025 19 June 2025